MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2023.1241600

Медицинская библиотека · Frontiers in immunology · 2023

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.

Sanchez María Belén, Vasconcelos Cordoba Bianca, Pavlovsky Carolina, Moiraghi Beatriz, Varela Ana, Custidiano Rosario, Fernandez Isolda, Freitas María Josefina, Ventriglia María Verónica, Bendek Georgina, Mariano Romina, Mela Osorio María José, Pavlovsky Miguel Arturo, García de Labanca Ana, Foncuberta Cecilia, Giere Isabel, Vera Masiel, Juni Mariana, Mordoh José, Sanchez Avalos Julio Cesar, Levy Estrella Mariel, Bianchini Michele

Клиническое исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the maintenance of TFR, and immunologic surveillance of the remaining leukemic cells is believed to be one of them. Argentina Stop Trial is an open-label, single-arm, multicenter trial assessing TFR after tyrosine kinase inhibitors interruption, that after more than 4 years showed a successful TFR rate of 63%.

METHODS

In this context, we set up an immunological study by flow cytometry in order to analyze specific NK cell subsets from peripheral blood patient samples both at the time of discontinuation as well as during the subsequent months.

RESULTS

At the time of discontinuation, patients show a mature NK cell phenotype, probably associated to TKI treatment. However, 3 months after discontinuation, significant changes in several NK cell receptors occurred. Patients with a higher proportion of CD56dim NK and PD-1+ NK cells showed better chances of survival. More interestingly, non-relapsing patients also presented a subpopulation of NK cells with features associated with the expansion after cytomegalovirus infection (expression of CD57+NKG2C+), and higher proportion of NKp30 and NKp46 natural cytotoxicity receptors, which resulted in greater degranulation and associated with better survival (p<0.0001).

DISCUSSION: This NK cell subset could have a protective role in patients who do not relapse, thus further characterization could be useful for patients in sustained deep molecular response.

Для цитирования: Sanchez María Belén, Vasconcelos Cordoba Bianca, Pavlovsky Carolina, Moiraghi Beatriz, Varela Ana, Custidiano Rosario, Fernandez Isolda, Freitas María Josefina, Ventriglia María Verónica, Bendek Georgina, Mariano Romina, Mela Osorio María José, Pavlovsky Miguel Arturo, García de Labanca Ana, Foncuberta Cecilia, Giere Isabel, Vera Masiel, Juni Mariana, Mordoh José, Sanchez Avalos Julio Cesar, Levy Estrella Mariel, Bianchini Michele. In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.. Frontiers in immunology. 2023. DOI: 10.3389/fimmu.2023.1241600.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.